报道经脐单孔腹腔镜脾部分切除术应用于儿童脾病中的经验。

回顾性分析2017年10月至2023年10月16例行经脐单孔腹腔镜脾部分切除术脾病患儿的临床资料。

(1)术前临床诊断并术后病理证实：脾囊肿5例，脾错构瘤4例，脾血管瘤4例，遗传性球形红细胞增多症3例；(2)病灶位于脾上叶，行脾上叶切除5例；病灶位于脾下叶，行脾下叶切除5例；病灶位于脾中叶3例，其中2例行脾中、下叶切除，1例术中出血转为脾动脉结扎术；3例遗传性球形红细胞增多症行脾中叶、下叶、部分脾上叶切除；(3)14例顺利完成经脐单孔腹腔镜手术，2例左上腹加孔完成手术；(4)术后均顺利出院，无出血及感染等并发症，随访3～55个月，良性瘤体均无复发，遗传性球形红细胞增多症患儿贫血显著改善。

经脐单孔腹腔镜脾部分切除术治疗儿童脾病是安全、可行的，在切除病灶的同时保留脾脏功能并具有最佳美容效果。

To report the experience of single-site laparoscopic partial splenectomy in the treatment of pediatric spleen diseases.

A retrospective analysis of clinical data was conducted for 16 children with spleen diseases who underwent single-site laparoscopic partial splenectomy from Oct. 2017 to Oct. 2023.

(1) Preoperative clinical diagnoses and postoperative pathological confirmations: 5 cases of splenic cysts, 4 cases of splenic hamartomas, 4 cases of splenic vascular malformations, and 3 cases of hereditary spherocytosis. (2) Lesions located in the upper pole or lower pole of the spleen were resected respectively in 5 cases; lesions in the middle pole were observed in 3 cases, with 2 undergoing resection of the middle and lower poles, and 1 case converting to splenic artery ligation due to intraoperative bleeding; 3 cases of hereditary spherocytosis underwent resection of the middle, lower, and partial upper poles. (3) Fourteen cases were successfully completed using single-incision laparoscopic surgery, and two cases required an additional port in the left upper abdomen to complete the procedure. (4) All patients were smoothly discharged postoperatively without complications such as bleeding or infection. Follow-up ranged from 3 to 55 months, with no recurrence observed in benign tumors, and significant improvement in anemia for children with hereditary spherocytosis.

Single-incision laparoscopic partial splenectomy is a safe and feasible method for treating pediatric spleen diseases. It allows for the removal of lesions while preserving splenic function and provides optimal cosmetic outcomes.